Second Department of Obstetrics and Gynecology, Athens University Medical School, Athens, Greece.
Reprod Sci. 2010 Jul;17(7):653-8. doi: 10.1177/1933719110366165. Epub 2010 Apr 1.
The aim of this study was to investigate possible alterations in circulating concentrations of surfactant protein D (SP-D)-an important component of the innate immune system that is upregulated in pulmonary diseases-in appropriate for gestational age (AGA) and intrauterine growth-restricted (IUGR) pregnancies, because the latter are characterized by structural lung immaturity, impaired immunocompetence, and increased risk of respiratory infections and chronic obstructive lung disease in later life. Serum SP-D concentrations were determined in 40 mothers and their 20 IUGR and 20 AGA full-term fetuses-neonates on postnatal day 1 (N1) and 4 (N4). Fetal SP-D concentrations were higher in the IUGR group (b = 18.16, 95% CI: 6.86-29.47, P = .002) and negatively correlated with infants' customized centiles and gestational age (r = -.326, P = .04, and r = -.446, P = .004, respectively). In both groups, fetal SP-D concentrations were lower than N1 and N4 ones (P <or= .015 in all cases). In the IUGR group, N1 SP-D concentrations were higher in vaginal deliveries (P = .032). Higher SP-D concentrations in IUGR fetuses may reflect structural lung immaturity, leading to increased alveolar-vascular permeability and protein leakage into the circulation. Alternatively, SP-D production may be increased due to intrauterine glucocorticoid exposure, leading to accelerated lung maturation. Surfactant protein D concentrations postnatally increase and are higher in neonates born vaginally, probably as a consequence of lung liquid reabsorption, concomitant with initiation of breathing and delivery stress. A progressive decrease in placental function may result in downregulated SP-D production, accounting for the negative correlation between fetal SP-D concentrations and gestational age.
本研究旨在探讨表面活性蛋白 D(SP-D)-一种在肺部疾病中上调的先天免疫系统的重要组成部分-在适当胎龄(AGA)和宫内生长受限(IUGR)妊娠中的循环浓度是否发生变化,因为后者的特征是结构肺不成熟、免疫功能受损以及在以后的生活中发生呼吸道感染和慢性阻塞性肺病的风险增加。在产后第 1 天(N1)和第 4 天(N4),测定了 40 名母亲及其 20 名 IUGR 和 20 名 AGA 足月胎儿-新生儿的血清 SP-D 浓度。IUGR 组胎儿 SP-D 浓度较高(b = 18.16,95%CI:6.86-29.47,P =.002),与婴儿的定制百分位数和胎龄呈负相关(r = -.326,P =.04 和 r = -.446,P =.004)。在两组中,胎儿 SP-D 浓度均低于 N1 和 N4 浓度(在所有情况下,P <or=.015)。在 IUGR 组中,阴道分娩的 N1 SP-D 浓度较高(P =.032)。IUGR 胎儿中较高的 SP-D 浓度可能反映了结构肺不成熟,导致肺泡-血管通透性增加和蛋白质渗漏到循环中。或者,SP-D 的产生可能由于宫内糖皮质激素暴露而增加,从而加速肺成熟。出生后 SP-D 浓度增加,且阴道分娩的新生儿浓度较高,可能是由于肺液吸收,同时开始呼吸和分娩应激。胎盘功能的逐渐下降可能导致 SP-D 产生下调,这解释了胎儿 SP-D 浓度与胎龄之间的负相关关系。